We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 09, 2021

Liraglutide and Triglyceride-Rich Lipoproteins in T2D

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Effects of Liraglutide on the Metabolism of Triglyceride-Rich Lipoproteins in Type 2 Diabetes
Diabetes Obes Metab 2021 Jan 27;[EPub Ahead of Print], MR Taskinen, E Björnson, N Matikainen, S Söderlund, KH Pietiläinen, M Ainola, A Hakkarainen, N Lundbom, J Fuchs, A Thorsell, L Andersson, M Adiels, CJ Packard, J Borén

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading